Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 4 of 5
Uncoated Bilayered Tablet
Flupirtine Maleate 100 mg + Paracetamol 325 mg Uncoated Bilayered Tablet is a uncoated bilayered tablet formulated with Flupirtine Maleate 100 mg + Paracetamol 325 mg. The active ingredient profile is Flupirtine Maleate; Paracetamol, placing the product i
Film-Coated Tablet
Hyoscine Butylbromide 10 mg + Paracetamol 325 mg Film-Coated Tablet is a film-coated tablet formulated with Hyoscine Butylbromide 10 mg + Paracetamol 325 mg. The active ingredient profile is Hyoscine Butylbromide; Paracetamol, placing the product in the a
Sugar-Coated Tablet
Hyoscine Butylbromide 10 mg Sugar-Coated Tablet is a sugar-coated tablet formulated with 10 mg. The active ingredient profile is Hyoscine Butylbromide, placing the product in the antispasmodic category. The active ingredient is an antispasmodic intended t
Film-Coated Tablet
Levocetirizine 2.5 mg + Montelukast 4 mg Film-Coated Tablet is a film-coated tablet formulated with Levocetirizine 2.5 mg + Montelukast 4 mg. The active ingredient profile is Levocetirizine; Montelukast, placing the product in the antihistamine + leukotri
Uncoated Bilayered Tablet
Levocetirizine 5 mg + Ambroxol SR 75 mg + Montelukast 10 mg Uncoated Bilayered Tablet is a uncoated bilayered tablet formulated with Levocetirizine 5 mg + Ambroxol SR 75 mg + Montelukast 10 mg. The active ingredient profile is Levocetirizine; Ambroxol; Mo
Film-Coated Tablet
Levocetirizine 5 mg Film-Coated Tablet is a film-coated tablet formulated with 5 mg. The active ingredient profile is Levocetirizine, placing the product in the second-generation antihistamine category. Levocetirizine is a second-generation antihistamine
Film-Coated Tablet
Levocetirizine Dihydrochloride 5 mg + Montelukast Sodium 10 mg + Ambroxol Hydrochloride 75 mg Film-Coated Tablet is a film-coated tablet formulated with Levocetirizine Dihydrochloride 5 mg + Montelukast Sodium 10 mg + Ambroxol Hydrochloride 75 mg. The act
Film-Coated Combination Tablet
Levofloxacin 250 mg + Ambroxol 75 mg SR Film-Coated Tablet is a film-coated combination tablet formulated with Levofloxacin 250 mg + Ambroxol 75 mg SR. The active ingredient profile is Levofloxacin; Ambroxol, placing the product in the fluoroquinolone ant
Film-Coated Tablet
Levofloxacin 250 mg Film-Coated Tablet is a film-coated tablet formulated with 250 mg. The active ingredient profile is Levofloxacin, placing the product in the fluoroquinolone antibiotic category. Levofloxacin is a fluoroquinolone antibiotic that inhibit
Film-Coated Tablet
Linagliptin 5 mg Film-Coated Tablet is a film-coated tablet formulated with 5 mg. The active ingredient profile is Linagliptin, placing the product in the dpp-4 inhibitor / oral antidiabetic category. Linagliptin is a DPP-4 inhibitor used as an oral gluco
Film-Coated Tablet
Linezolid 600 mg Film-Coated Tablet is a film-coated tablet formulated with 600 mg. The active ingredient profile is Linezolid, placing the product in the oxazolidinone antibiotic category. Linezolid is an oxazolidinone antibiotic that inhibits bacterial
Uncoated Tablet
Linezolid 600 mg Uncoated Tablet is a uncoated tablet formulated with 600 mg. The active ingredient profile is Linezolid, placing the product in the oxazolidinone antibiotic category. Linezolid is an oxazolidinone antibiotic that inhibits bacterial protei
Film-Coated Tablet
Lomefloxacin 400 mg Film-Coated Tablet is a film-coated tablet formulated with 400 mg. The active ingredient profile is Lomefloxacin, placing the product in the fluoroquinolone antibiotic category. The active ingredient is an antibacterial agent intended
Film-Coated Tablet
Lornoxicam 8 mg Film-Coated Tablet is a film-coated tablet formulated with 8 mg. The active ingredient profile is Lornoxicam, placing the product in the nsaid / analgesic anti-inflammatory category. The formulation contains an NSAID and/or non-opioid anal
Uncoated Tablet
Mefenamic Acid 500 mg + Dicyclomine HCl 20 mg Uncoated Tablet is a uncoated tablet formulated with Mefenamic Acid 500 mg + Dicyclomine HCl 20 mg. The active ingredient profile is Mefenamic Acid; Dicyclomine HCl, placing the product in the nsaid + antispas
Uncoated Tablet
Mefenamic Acid 500 mg + Paracetamol 325 mg Uncoated Tablet is a uncoated tablet formulated with Mefenamic Acid 500 mg + Paracetamol 325 mg. The active ingredient profile is Mefenamic Acid; Paracetamol, placing the product in the nsaid + analgesic combinat
Film-Coated Tablet
Moxifloxacin 400 mg Film-Coated Tablet is a film-coated tablet formulated with 400 mg. The active ingredient profile is Moxifloxacin, placing the product in the fluoroquinolone antibiotic category. Moxifloxacin is a fluoroquinolone antibiotic that inhibit
Film-Coated Tablet
Naproxen 250 mg + Domperidone 10 mg Film-Coated Tablet is a film-coated tablet formulated with Naproxen 250 mg + Domperidone 10 mg. The active ingredient profile is Naproxen; Domperidone, placing the product in the nsaid + antiemetic / prokinetic combinat
Film-Coated Tablet
Naproxen 250 mg Film-Coated Tablet is a film-coated tablet formulated with 250 mg. The active ingredient profile is Naproxen, placing the product in the nsaid / analgesic anti-inflammatory category. The formulation contains an NSAID and/or non-opioid anal
Uncoated Tablet
Nimesulide (in Beta-Cyclodextrin BP) 100 mg Uncoated Tablet is a uncoated tablet formulated with 100 mg. The active ingredient profile is Nimesulide in Beta-Cyclodextrin, placing the product in the nsaid / analgesic anti-inflammatory category. Nimesulide
Uncoated Tablet
Nimesulide 100 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Uncoated Tablet is a uncoated tablet formulated with Nimesulide 100 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Nimesulide; Paracetamol; Chlorzoxazone, plac
Film-Coated Tablet
Nimesulide 100 mg + Paracetamol 325 mg + Serratiopeptidase 15 mg Film-Coated Tablet is a film-coated tablet formulated with Nimesulide 100 mg + Paracetamol 325 mg + Serratiopeptidase 15 mg. The active ingredient profile is Nimesulide; Paracetamol; Serrati
Uncoated Tablet
Nimesulide 100 mg + Paracetamol 325 mg Uncoated Tablet is a uncoated tablet formulated with Nimesulide 100 mg + Paracetamol 325 mg. The active ingredient profile is Nimesulide; Paracetamol, placing the product in the nsaid + analgesic combination category
Tablet
Nimesulide 100 mg + Phenylephrine HCl 10 mg + Unspecified Dihydrochloride 5 mg + Caffeine 30 mg Tablet is a tablet formulated with Nimesulide 100 mg + Phenylephrine HCl 10 mg + unspecified dihydrochloride 5 mg + Caffeine 30 mg. The active ingredient profi
Sustained-Release Film-Coated Tablet
Nitrofurantoin 100 mg SR Film-Coated Tablet is a sustained-release film-coated tablet formulated with 100 mg. The active ingredient profile is Nitrofurantoin, placing the product in the urinary antibacterial category. Nitrofurantoin is a urinary antibacte
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
